Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization

Abstract

// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Zongguo Yang1, Jianliang Zhang1, Yunfei Lu1, Qingnian Xu1, Bozong Tang1, Qiang Wang1, Wensi Zhang1, Shishi Chen1, Lingqing Lu1, Xiaorong Chen1 1Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China Correspondence to: Xiaorong Chen, e-mail: xiaorong3chen@163.com Zongguo Yang, e-mail: dr_yangzg@aliyun.com Keywords: lymphocyte cell, aspartate aminotransferase-lymphocyte ratio index, systemic immune-inflammation index, survival, hepatocellular carcinoma Received: August 03, 2015 Accepted: September 16, 2015 Published: October 16, 2015